First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the role of an additional intraperitoneal
chemotherapy with cisplatin and etoposide in bulky advanced epithelial ovarian cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Gynecologic Oncology Group
Collaborators:
Fudan University Shanghai Jiao Tong University School of Medicine Shanghai Zhongshan Hospital